Literature DB >> 9212761

A new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum, and acne: PAPA syndrome.

N M Lindor1, T M Arsenault, H Solomon, C E Seidman, M T McEvoy.   

Abstract

OBJECTIVE: To describe a multigenerational family with transmission of an autosomal dominant disorder characterized by pyogenic arthritis, pyoderma gangrenosum, and severe cystic acne.
MATERIAL AND METHODS: We present a detailed case report of a 39-year-old man with arthritic changes in several joints, pyoderma gangrenosum, and cystic acne. Several relatives from three generations of his family underwent clinical and genetic investigations. The findings in this kindred are reported.
RESULTS: Ten affected family members in three generations manifested variable expression of a pauciarticular, nonaxial, destructive, corticosteroid-responsive arthritis that began in childhood; pyoderma gangrenosum; and severe cystic acne in adolescence and beyond. Other less commonly associated features included adult-onset insulin-dependent diabetes mellitus, proteinuria, abscess formation at the site of parenteral injections, and cytopenias attributable to sulfonamide medications. Laboratory evaluation was nondiagnostic. Genetic studies excluded linkage to the major histocompatibility locus.
CONCLUSION: The acronym of PAPA syndrome (pyogenic sterile arthritis, pyoderma gangrenosum, and acne) is suggested for this newly recognized pleiotropic autosomal dominant disorder. The nature of the genetic alteration in PAPA syndrome is unknown.

Entities:  

Mesh:

Year:  1997        PMID: 9212761     DOI: 10.1016/S0025-6196(11)63565-9

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  66 in total

1.  Brief report: genotype, phenotype, and clinical course in five patients with PAPA syndrome (pyogenic sterile arthritis, pyoderma gangrenosum, and acne).

Authors:  Andrew P Demidowich; Alexandra F Freeman; Douglas B Kuhns; Ivona Aksentijevich; John I Gallin; Maria L Turner; Daniel L Kastner; Steven M Holland
Journal:  Arthritis Rheum       Date:  2011-12-12

2.  Retropharyngeal and splenic aseptic abscesses treated with prednisone and cyclophosphamide in a patient with ulcerative colitis.

Authors:  Marc André; Jean-Charles Piette; Camille Frances; Bertrand Wechsler; Isabelle Delevaux; Olivier Aumaître
Journal:  Dig Dis Sci       Date:  2003-06       Impact factor: 3.199

Review 3.  Inflammasome-mediated autoinflammatory disorders.

Authors:  Shruti P Wilson; Suzanne L Cassel
Journal:  Postgrad Med       Date:  2010-09       Impact factor: 3.840

Review 4.  Neutrophilic dermatoses and autoinflammatory diseases with skin involvement--innate immune disorders.

Authors:  Alexander A Navarini; Takashi K Satoh; Lars E French
Journal:  Semin Immunopathol       Date:  2015-11-30       Impact factor: 9.623

Review 5.  [Clinical variants of acne].

Authors:  T Jansen; S Grabbe; G Plewig
Journal:  Hautarzt       Date:  2005-11       Impact factor: 0.751

Review 6.  Recurrent febrile syndromes: what a rheumatologist needs to know.

Authors:  Hal M Hoffman; Anna Simon
Journal:  Nat Rev Rheumatol       Date:  2009-05       Impact factor: 20.543

Review 7.  [Diagnostics and therapy of AA amyloidosis].

Authors:  N Blank; H M Lorenz
Journal:  Pathologe       Date:  2009-05       Impact factor: 1.011

Review 8.  Autoinflammatory diseases in childhood, part 1: monogenic syndromes.

Authors:  María Navallas; Emilio J Inarejos Clemente; Estíbaliz Iglesias; Mónica Rebollo-Polo; Faizah Mohd Zaki; Oscar M Navarro
Journal:  Pediatr Radiol       Date:  2020-02-17

9.  Isotretinoin use and the risk of inflammatory bowel disease: a population-based cohort study.

Authors:  Raed O Alhusayen; David N Juurlink; Muhammad M Mamdani; Richard L Morrow; Neil H Shear; Colin R Dormuth
Journal:  J Invest Dermatol       Date:  2012-10-25       Impact factor: 8.551

10.  Pyrin binds the PSTPIP1/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway.

Authors:  Nitza G Shoham; Michael Centola; Elizabeth Mansfield; Keith M Hull; Geryl Wood; Carol A Wise; Daniel L Kastner
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-31       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.